Skip to content

Total debt at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$5.24M-19.5%
PTH
Pelthos Therapeutics Inc.PTHS
$29.65M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$68.36M+5,079%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.15M-98.1%
Opko Health logo
Opko HealthOPK
$52.78M-4.2%
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.4%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Calculated from Scilex Holding Company’s reported figures.

Plus components not separately reported this period.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's total debt?
Scilex Holding Company (SCLX) reported total debt of $95.35M in Q1 2026.
How has Scilex Holding Company's total debt changed year-over-year?
Scilex Holding Company's total debt increased by 129.7% year-over-year, from $41.51M to $95.35M.
What is the long-term trend for Scilex Holding Company's total debt?
Over 4 years (2021 to 2025), Scilex Holding Company's total debt has grown at a 2.0% compound annual growth rate (CAGR), from $111.64M to $120.63M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.